Societal CDMO (SCTL)

Company Profile

Recro Pharma Inc. is a contract development and manufacturing organization (CDMO) with capabilities from early feasibility to commercial manufacturing. With an expertise in solving complex manufacturing problems, Recro is a leading CDMO providing oral solid dosage form development, end-to-end regulatory support, clinical and commercial manufacturing, and packaging and logistics services to the global pharmaceutical market.

Company profile

Ticker

SCTL

Exchange

NASDAQ

Website

www.recropharma.com

CEO

Gerri A. Henwood

Incorporated

Pennsylvania

Location

Pennsylvania

Fiscal year end

Dec 31

Sector

Manufacturing > Pharmaceutical Preparation Manufacturing

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co • Abbott Laboratories • Teva- Pharmaceutical Industries • Bristol-Myers Squibb • Lilly(Eli) & Co • Viatris • Abbvie • Bausch Health Companies ...

Former names

Recro Pharma, Inc.

SEC CIK

0001588972

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Societal CDMO Gainesville, LLC • Societal CDMO Gainesville Development, LLC • Societal CDMO San Diego, LLC ...

SCTL stock data

1M 1Y 5Y

Latest filings (excl ownership)

View all

8-K

Regulation FD Disclosure

13 Mar 23

S-8

Registration of securities for employees

1 Mar 23

S-8

Registration of securities for employees

Societal CDMO Reports Fourth Quarter and Full Year 2022 Financial Results

1 Mar 23

8-K

Departure of Directors or Certain Officers

3 Jan 23

8-K

Completion of Acquisition or Disposition of Assets

20 Dec 22

424B5

Prospectus supplement for primary offering

13 Dec 22

8-K

Entry into a Material Definitive Agreement

13 Dec 22

424B5

Prospectus supplement for primary offering

13 Dec 22

Transcripts

View all

SCTL

Earnings call transcript

2022 Q4

1 Mar 23

SCTL

Earnings call transcript

2022 Q3

10 Nov 22

SCTL

Earnings call transcript

2022 Q2

11 Aug 22

SCTL

Earnings call transcript

2022 Q1

12 May 22

SCTL

Earnings call transcript

2021 Q3

10 Nov 21

SCTL

Earnings call transcript

2021 Q2

9 Aug 21

SCTL

Earnings call transcript

2021 Q1

9 May 21

SCTL

Earnings call transcript

2020 Q4

28 Feb 21

SCTL

Earnings call transcript

2020 Q3

10 Nov 20

SCTL

Earnings call transcript

2020 Q2

10 Aug 20

Latest ownership filings

View all

Ryan David Lake

2 Mar 23

SC 13G/A

Athyrium Funds GP Holdings LLC

14 Feb 23

SC 13G/A

AWM Investment Company, Inc.

Initial statement of insider ownership

Financial summary

Financial statements Chart SCTL financial data

Quarter (USD)	Dec 22	Sep 22	Jun 22	Mar 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21	Dec 20	Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	15.00 mm	15.00 mm	15.00 mm	15.00 mm	15.00 mm	15.00 mm
Cash burn (monthly)	(no burn)	851.83 k	(no burn)	(no burn)	831.00 k	677.58 k
Cash used (since last report)	n/a	2.34 mm	n/a	n/a	2.29 mm	1.86 mm
Cash remaining	n/a	12.65 mm	n/a	n/a	12.71 mm	13.13 mm
Runway (months of cash)	n/a	14.9	n/a	n/a	15.3	19.4

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2022

SCTL institutional ownership history Ownership history

62.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	48	50	-4.0%
Opened positions	5	4	+25.0%
Closed positions	7	8	-12.5%
Increased positions	11	10	+10.0%
Reduced positions	12	15	-20.0%

13F shares	Current	Prev Q	Change
Total value	54.14 mm	36.32 mm	+49.1%
Total shares	35.18 mm	35.49 mm	-0.9%
Total puts	0.00	0.00
Total calls	191.10 k	251.70 k	-24.1%
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
AWM Investment	5.61 mm	$9.14 mm	0.0%
Gerald Joseph Yakatan & Una Yakatan Family Trust dated April 4, 1989 as amended & fully restated on May 3, 2017	5.00 mm	$0.00	0.0%
Railroad Ranch Capital Management	4.02 mm	$5.06 mm	+20.1%
Cowen Prime Advisors	3.21 mm	$5.23 mm	-0.6%
Samjo Capital	2.62 mm	$3.24 mm	+6.9%
Athyrium Funds GP	2.55 mm	$11.63 mm	0.0%
Athyrium Capital Management	2.20 mm	$3.59 mm	0.0%
Vanguard	1.68 mm	$2.74 mm	0.0%
Rubric Capital Management	1.08 mm	$1.76 mm	0.0%
Alyeska Investment	1.07 mm	$1.74 mm	0.0%

Largest transactions	Shares	Bought/sold	Change
Railroad Ranch Capital Management	4.02 mm	+673.74 k	+20.1%
Russell Investments	300.43 k	-500.23 k	-62.5%
Cantor Fitzgerald, L. P.	0.00	-325.00 k	EXIT
Samjo Capital	2.62 mm	+170.00 k	+6.9%
First Eagle Investment Management	1.02 mm	+144.43 k	+16.5%
D. E. Shaw & Co.	77.34 k	-134.20 k	-63.4%
STT State Street	0.00	-115.38 k	EXIT
Boston Partners	92.25 k	-106.47 k	-53.6%
Renaissance Technologies	957.93 k	-75.47 k	-7.3%
Frontier Wealth Management	0.00	-65.01 k	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

SCTL insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
28 Feb 23	Lake Ryan David	Common Stock	Payment of exercise	Dispose F	No	No	1.47	1,197	1.76 k	780,991
3 Feb 23	Lake Ryan David	Common Stock	Payment of exercise	Dispose F	No	No	1.36	862	1.17 k	782,188
31 Jan 23	Lake Ryan David	Common Stock	Payment of exercise	Dispose F	No	No	1.3	1,198	1.56 k	783,050
20 Jan 23	Lake Ryan David	Common Stock	Payment of exercise	Dispose F	No	No	1.36	14,438	19.64 k	784,248
20 Jan 23	J David Enloe JR	Common Stock	Payment of exercise	Dispose F	No	No	1.36	31,046	42.22 k	973,940
19 Jan 23	Lake Ryan David	Common Stock	Grant	Acquire A	No	No	0	230,944	0.00	798,686
19 Jan 23	Lake Ryan David	Common Stock	Payment of exercise	Dispose F	No	No	1.35	28,374	38.30 k	567,742
19 Jan 23	Lake Ryan David	Common Stock	Grant	Acquire A	No	No	0	84,848	0.00	596,116
19 Jan 23	Lake Ryan David	Stock Option Common Stock	Grant	Acquire A	No	No	1.35	160,929	217.25 k	160,929
19 Jan 23	J David Enloe JR	Common Stock	Grant	Acquire A	No	No	0	412,401	0.00	1,004,986